Zoster (Shingles)

Risk factors: maternal varicella during pregnancy, or primary varicella in first year of life.

 

Herpes zoster ophthalmicus - involvement of cranial nerve V1 occurs in 10-25% of herpes zoster (HZ) cases. Blisters on tip of nose may be seen. Consult ophthalmology.

 

Ramsay-Hunt syndrome - severe ear pain, facial muscle weakness, and rash indicates infection of facial nerve. Consult otolaryngologist.

 

Immunity is boosted once a person has herpes zoster, so recurrence is uncommon (≤ 5%) in immunocompetent persons.

 

Direct contact with the skin lesions of a person with regional/limited herpes zoster, or via airborne route in disseminated zoster, can lead to varicella (chicken pox) in persons who have not had varicella or been immunized.

Immunocompetent

- Therapy recommended if:

  • ophthalmic involvement

  • Ramsay-Hunt syndrome

  • disseminated beyond two dermatomes.

- Topical therapy not recommended as ineffective.

- Therapy should be started within 72h of rash onset, or at any time if new vesicles forming or cutaneous/motor/neurologic/ocular complications.

 
Usual Pathogens

Varicella zoster

 

Therapy Dose Duration
Acyclovir 80mg/kg/d PO div 5x/d 7 days

Immunocompromised

- Therapy ideally should be started within 72h of rash onset, or at any time if new vesicles forming or cutaneous/motor/neurologic/ocular complications.

 
Usual Pathogens

Varicella zoster

 

Mild

Therapy Dose Duration
Acyclovir 80mg/kg/d PO div 5x/d 7-10 days

Moderate-severe/Disseminated

Therapy Dose Duration
Acyclovir 60mg/kg/d IV div q8h 7-10 days